These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

613 related articles for article (PubMed ID: 33301014)

  • 41. Pooling samples: a testing option for SARS-CoV-2 during a supply shortage.
    Salimnia H; Mitchell R; Gundel A; Cambell A; Gammou F; Chopra T; Fairfax M
    Diagn Microbiol Infect Dis; 2021 Jan; 99(1):115205. PubMed ID: 33190092
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Missing Piece - SARS-CoV-2 Testing and School Reopening.
    Rafiei Y; Mello MM
    N Engl J Med; 2020 Dec; 383(23):e126. PubMed ID: 33085856
    [No Abstract]   [Full Text] [Related]  

  • 43. Universal screening for novel coronavirus disease 2019 (COVID-19) for asymptomatic parturients: May not be beneficial at this time.
    Henderson CE; Rezai S; Jackman JM
    J Med Virol; 2021 Mar; 93(3):1198-1200. PubMed ID: 32915477
    [No Abstract]   [Full Text] [Related]  

  • 44. Simple Questionnaires to Improve Pooling Strategies for SARS-CoV-2 Laboratory Testing.
    Schneitler S; Jung P; Bub F; Alhussein F; Benthien S; Berger FK; Berkó-Göttel B; Eisenbeis J; Hahn D; Halfmann A; Last K; Linxweiler M; Lohse S; Papan C; Pfuhl T; Rissland J; Roth S; Schlotthauer U; Utzinger J; Smola S; Gärtner BC; Becker SL
    Ann Glob Health; 2020 Nov; 86(1):148. PubMed ID: 33262937
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Universal screening identifies asymptomatic carriers of SARS-CoV-2 among pregnant women in India.
    Waghmare R; Gajbhiye R; Mahajan NN; Modi D; Mukherjee S; Mahale SD
    Eur J Obstet Gynecol Reprod Biol; 2021 Jan; 256():503-505. PubMed ID: 33393481
    [No Abstract]   [Full Text] [Related]  

  • 46. Saliva as a gold-standard sample for SARS-CoV-2 detection.
    Tan SH; Allicock O; Armstrong-Hough M; Wyllie AL
    Lancet Respir Med; 2021 Jun; 9(6):562-564. PubMed ID: 33887248
    [No Abstract]   [Full Text] [Related]  

  • 47. Occurrence of SARS-CoV-2 in the intraocular milieu.
    List W; Regitnig P; Kashofer K; Gorkiewicz G; Zacharias M; Wedrich A; Posch-Pertl L
    Exp Eye Res; 2020 Dec; 201():108273. PubMed ID: 32991885
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Patients With Inflammatory Bowel Disease Under Biologic Treatment.
    Norsa L; Cosimo P; Indriolo A; Sansotta N; D'Antiga L; Callegaro A
    Gastroenterology; 2020 Dec; 159(6):2229-2231.e2. PubMed ID: 32860790
    [No Abstract]   [Full Text] [Related]  

  • 49. COVID-19 in pregnancy in South Africa: Tracking the epidemic and defining the natural history.
    Fairlie L; Sawry S; Patel F; Balkus JE; Kalk E; Mutevedzi P; Technau KG; Yates LM; Slogrove A; Ballot D; Bandini RM; Mehta U; Moodley D; Mhlongo O; Budram S; Maswime S; Vannevel V; Rees H; Chersich M
    S Afr Med J; 2020 Jul; 110(8):729-731. PubMed ID: 32880298
    [No Abstract]   [Full Text] [Related]  

  • 50. Regional variation in trajectories of healthcare worker infections during the COVID-19 pandemic in Italy.
    Bellizzi S; Panu Napodano CM; Salaris P; Pichierri G; Sotgiu G
    Infect Control Hosp Epidemiol; 2020 Dec; 41(12):1472-1474. PubMed ID: 32362294
    [No Abstract]   [Full Text] [Related]  

  • 51. Serial simultaneously self-swabbed samples from multiple sites show similarly decreasing SARS-CoV-2 loads in COVID-19 cases of differing clinical severity.
    Pan D; Sze S; Rogers B; Bron J; Bird PW; Holmes CW; Tang JW
    J Infect; 2020 Dec; 81(6):979-997. PubMed ID: 32956734
    [No Abstract]   [Full Text] [Related]  

  • 52. Optimum Naso-oropharyngeal Swab Procedure for COVID-19: Step-by-Step Preparation and Technical Hints.
    Coden E; Russo F; Arosio AD; Castelnuovo P; Karligkiotis A; Volpi L
    Laryngoscope; 2020 Nov; 130(11):2564-2567. PubMed ID: 32716074
    [No Abstract]   [Full Text] [Related]  

  • 53. Role of presymptomatic transmission of COVID-19: evidence from Beijing, China.
    Zhang Y; Muscatello D; Tian Y; Chen Y; Li S; Duan W; Ma C; Sun Y; Wu S; Ge L; Yang P; Jia L; Wang Q; MacIntyre CR
    J Epidemiol Community Health; 2021 Jan; 75(1):84-87. PubMed ID: 32855261
    [TBL] [Abstract][Full Text] [Related]  

  • 54. DNA Cross-Reactivity of the CDC-Specified SARS-CoV-2 Specimen Control Leads to Potential for False Negatives and Underreporting of Viral Infection.
    Rosebrock AP
    Clin Chem; 2021 Jan; 67(2):435-437. PubMed ID: 33313692
    [No Abstract]   [Full Text] [Related]  

  • 55. Serological tests facilitate identification of asymptomatic SARS-CoV-2 infection in Wuhan, China.
    Wu X; Fu B; Chen L; Feng Y
    J Med Virol; 2020 Oct; 92(10):1795-1796. PubMed ID: 32311142
    [No Abstract]   [Full Text] [Related]  

  • 56. Universal masking is an effective strategy to flatten the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) healthcare worker epidemiologic curve.
    Seidelman JL; Lewis SS; Advani SD; Akinboyo IC; Epling C; Case M; Said K; Yancey W; Stiegel M; Schwartz A; Stout J; Sexton DJ; Smith BA
    Infect Control Hosp Epidemiol; 2020 Dec; 41(12):1466-1467. PubMed ID: 32576336
    [No Abstract]   [Full Text] [Related]  

  • 57. Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19.
    Li K; Huang B; Wu M; Zhong A; Li L; Cai Y; Wang Z; Wu L; Zhu M; Li J; Wang Z; Wu W; Li W; Bosco B; Gan Z; Qiao Q; Wu J; Wang Q; Wang S; Xia X
    Nat Commun; 2020 Nov; 11(1):6044. PubMed ID: 33247152
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mass population screening for SARS-CoV-2 and false positives-why Liverpool shows we have a problem.
    Cook D
    BMJ; 2020 Dec; 371():m4954. PubMed ID: 33384318
    [No Abstract]   [Full Text] [Related]  

  • 59. Just 2% of SARS-CoV-2-positive individuals carry 90% of the virus circulating in communities.
    Yang Q; Saldi TK; Gonzales PK; Lasda E; Decker CJ; Tat KL; Fink MR; Hager CR; Davis JC; Ozeroff CD; Muhlrad D; Clark SK; Fattor WT; Meyerson NR; Paige CL; Gilchrist AR; Barbachano-Guerrero A; Worden-Sapper ER; Wu SS; Brisson GR; McQueen MB; Dowell RD; Leinwand L; Parker R; Sawyer SL
    Proc Natl Acad Sci U S A; 2021 May; 118(21):. PubMed ID: 33972412
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Response of Clinical Laboratories to the Ongoing COVID-19 Pandemic.
    Kim YJ; Sung H; Ki CS; Hur M
    Ann Lab Med; 2021 Nov; 41(6):519-520. PubMed ID: 34108278
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.